Share of people with HIV who receive antiretroviral therapy in Guinea-Bissau
Guinea-Bissau: Share of people with HIV who receive antiretroviral therapy was 79.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Guinea-Bissau, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Guinea-Bissau stood at 79.0%. That is the highest value across all 25 years on record.
That represents a change of up 21.5% on the previous year and up 259.1% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Guinea-Bissau peaked at 79.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Guinea-Bissau 53rd out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Guinea-Bissau, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 2.0% | +100.0% |
| 2008 | 5.0% | +150.0% |
| 2009 | 8.0% | +60.0% |
| 2010 | 10.0% | +25.0% |
| 2011 | 13.0% | +30.0% |
| 2012 | 17.0% | +30.8% |
| 2013 | 18.0% | +5.9% |
| 2014 | 22.0% | +22.2% |
| 2015 | 26.0% | +18.2% |
| 2016 | 32.0% | +23.1% |
| 2017 | 33.0% | +3.1% |
| 2018 | 42.0% | +27.3% |
| 2019 | 47.0% | +11.9% |
| 2020 | 51.0% | +8.5% |
| 2021 | 57.0% | +11.8% |
| 2022 | 64.0% | +12.3% |
| 2023 | 65.0% | +1.6% |
| 2024 | 79.0% | +21.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.6% | 0.0% | 8.0% | 10 |
| 2010s | 26.0% | 10.0% | 47.0% | 10 |
| 2020s | 63.2% | 51.0% | 79.0% | 5 |
Countries ranked near Guinea-Bissau
More health data for Guinea-Bissau
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7721 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,070 deaths per 1,000 people (2090)
- Number of infants who die before age 1 941 deaths (2100)
- Population ages 40-44, male, annual growth rate 3.78 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0255 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.39 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0215 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Guinea-Bissau?
- Share of people with hiv who receive antiretroviral therapy in Guinea-Bissau was 79.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Guinea-Bissau?
- The highest recorded value was 79.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Guinea-Bissau?
- The lowest recorded value was 0.0% in 2000.
- How does Guinea-Bissau rank for share of people with hiv who receive antiretroviral therapy?
- Guinea-Bissau ranks 53rd out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Guinea-Bissau?
- Over the last ten years it is up 259.1%. The long-run trend across the full record is volatile.
- Where does this Guinea-Bissau data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.